Investors who lost money on Applied Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - APLT
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Applied Therapeutics, Inc. (NASDAQ:APLT) for potential federal securities law violations. This follows the FDA's issuance of a Complete Response Letter for the company's drug application for govorestat.
December 06, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics is under investigation by Levi & Korsinsky for potential securities law violations after the FDA issued a Complete Response Letter for its drug govorestat.
The investigation by Levi & Korsinsky into potential securities law violations is significant, as it could lead to legal challenges and affect investor confidence. The FDA's Complete Response Letter indicates regulatory hurdles for govorestat, potentially delaying its market entry and impacting revenue expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100